One study in K562 (chronic myelogenous leukemia) cells identified distinct requirements for different PAF1C components in stimulating RNAPII activity, with degradation of the PAF1 subunit only weakly affecting RNA synthesis95. Here, PAF1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.